Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 13:2022:3117661.
doi: 10.1155/2022/3117661. eCollection 2022.

Synthesis and Characterization of Novel [2 + 1] Tricarbonyl Rhenium Complexes with the Hydrophilic Phosphine Ligands PTA and CAP

Affiliations

Synthesis and Characterization of Novel [2 + 1] Tricarbonyl Rhenium Complexes with the Hydrophilic Phosphine Ligands PTA and CAP

Ioanna Roupa et al. Bioinorg Chem Appl. .

Abstract

In the pursuit of hydrophilic model fac-[Re(CO)3]+ complexes for (radio) pharmaceutical applications, six novel [2 + 1] mixed-ligand complexes of the general type fac-[Re(CO)3(bid)P] were synthesized and characterized, where bid is a bidentate ligand bearing either (N, O) or (S, S') donor atom sets and P is the hydrophilic phosphine 1,3,5-triaza-7-phosphoadamantane (PTA) or its macrocyclic homologue 1,4,7-triaza-9-phosphatricyclo[5.3.2.1]tridecane (CAP). The (N, O) ligands used in this study were picolinic and quinaldic acid, while the (S, S') ligand was diethyldithiocarbamate. The complexes were synthesized in generally high yields and purity and the characterization was performed by spectroscopic methods, IR, NMR, and elemental analysis. Detailed X-ray crystallographic study of molecular packing by using Hirshfeld analysis tools revealed a plethora of intermolecular interactions such as hydrogen bond, ππ, C-H⋯π, and carbonyl-carbonyl interactions. To our knowledge, the CAP complexes reported herein are the first example of [2 + 1] mixed-ligand fac-[Re(CO)3]+ complexes with CAP. The new complexes might have the potential to serve as platforms for the design of target-specific complexes with favorable pharmacokinetics.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Scheme 1
Scheme 1
Synthesis of complexes 1a-3a and 1b-3b. Reactions and conditions: (a) quinH, H2O, 60°C, 1 h; (b) X, MeOH, reflux, 2 h; (c) picH, H2O, 70°C, 3 h; (d) X, MeOH, reflux, 2 h; (e) Et2SS, X MeOH, reflux, 2 h.
Figure 1
Figure 1
Partially labelled plots of 1b (a) and 2b (b).
Figure 2
Figure 2
Partially labelled plots of 3a (a) and 3b (b).
Figure 3
Figure 3
Intermolecular interactions observed in the structure of compound 1b. Dashed thick dark green (antiparallel C3-O3⋯C3-O3) and dark red lines indicate carbonyl-carbonyl interactions (C-O5⋯C1-O1). Dark violet dashed lines indicate C19-H19π interactions. Light green dashed lines indicate ππ between quinaldic ligands and orange dashed lines indicate C18-H18A⋯O2, C14-H14B⋯O2 and C9-H9⋯O5 hydrogen bonds.
Figure 4
Figure 4
(a), (b) Different views of the dnorm decorated HS, (c) two views of the shape decorated HS, and (d) fingerprint plot for the 1b complex. A1, A2, A3 and B1, B2, B3 are the donor and acceptor contact points of C18-H18(A)⋯O2, C14-H14(B)⋯O2, C9-H9⋯O5 hydrogen bond interactions. The green ellipse in (a) indicates the area of antiparallel CO⋯CO, C3≡O3 carbonyl interactions. E1, E2 and D1, D2 are the donor and acceptor contact points involved in the M-C⋯CO, O5⋯C1‴ type of interactions. The white and orange ellipses in (c) indicate ππ and C-H⋯π (F1 and G1 are donor and acceptor contact points, respectively, Table 5) type of interactions.
Figure 5
Figure 5
Intermolecular interactions among neighboring clusters in the structure of compound 2b. The different type of hydrogen bond interactions is indicated with dashed thick orange (C12-H12⋯O2), dark red (C14-H14A⋯O5 and C15-H15B⋯O5 pairs of interactions), and cyan (C8-H8⋯O4) dashed lines. The pink dashed lines indicate carbonyl C8-H8⋯C1 type of interactions. C6-H6⋯O5, C9-H9⋯O1 and C16-H16∙∙∙Cg2 (C-H⋯π type of interactions) are indicated with violet, yellow, and dark green dashed lines, respectively.
Figure 6
Figure 6
(a) Different views of the dnorm decorated HS, (b) two views of the shape decorated HS and (c) fingerprint plot for the 2b complex. A1, A2, A3, A4, A5, A6 and B1, B2, B3, B4, B5, B6 are the donor and acceptor contact points of C12—H12B⋯O2, C14—H14A⋯O5, C15—H15A⋯O5, C6—H6⋯O5, C8—H8⋯O4 and C9—H9⋯O1 hydrogen bond interactions. E1, E2 and D1, D2 are the donor and acceptor contact points involved in the C13-H13⋯Cg2 and C16-H16···Cg2 C-H⋯π type of interactions. E3 and D3 are the donor and acceptor contact points of C8-H8⋯C1 type of interactions.
Figure 7
Figure 7
Stacking of layers along the c crystallographic axis in the structure of compound 3a. Braces indicate the position of layers and arrows the carbonyl-carbonyl interactions. The dashed thick orange lines indicate C9-H9A⋯N4 and C9-H9B⋯N3 and the dark red one indicates C13-H13A⋯O1 hydrogen bonds. Dashed thick dark green lines indicate antiparallel CO⋯CO carbonyl-carbonyl interactions. Details for the arrangement of complexes and the intermolecular interactions within the layer are presented in Figure S3.
Figure 8
Figure 8
(a), Different views of the dnorm decorated HS and (b) fingerprint plot for the 3a complex. A1, A2, A3 and B1, B2, B3 are the donor and acceptor contact points of C9—H9(A)⋯N4, C9—H9(B)⋯N3 and C13—H13A⋯O1(indicated with orange arrows in fingerprint plot) hydrogen bond interactions (Table 5). Label D indicates the area of antiparallel CO⋯CO, C3≡O3 carbonyl interactions. Red arrows in the fingerprint plot indicate the C⋯H/⋯C contact points.
Figure 9
Figure 9
Stacking of layers along the b crystallographic axis in the structure of compound 3b, The dashed thick orange, dark red, and cyan lines indicate C8-H8A⋯O2, C5-H5⋯S2 and C6-H6B⋯N2 hydrogen bonds, respectively. Details for the arrangement of complexes and the intermolecular interactions within the layer are presented in Figure S4.
Figure 10
Figure 10
(a) Different views of the dnorm decorated HS and (b) fingerprint plot for the 3b complex. A1, A2, A3 and B1, B2, B3 are the donor and acceptor contact points of C8-H8A⋯O2, C5-H5A∙∙S2 and C6-H6B⋯N2 hydrogen bond interactions (Table 5).

Similar articles

Cited by

References

    1. Lepareur N., Lacœuille F., Bouvry C., et al. Rhenium-188 labeled radiopharmaceuticals: current clinical applications in oncology and promising perspectives. Frontiers of Medicine . 2019;6:p. 132. doi: 10.3389/fmed.2019.00132. - DOI - PMC - PubMed
    1. Abram U., Alberto R. Technetium and rhenium: coordination chemistry and nuclear medical applications. Journal of the Brazilian Chemical Society . 2006;17(8):1486–1500. doi: 10.1590/s0103-50532006000800004. - DOI
    1. Konkankit C. C., Marker S. C., Knopf K. M., Wilson J. J. Anticancer activity of complexes of the third row transition metals, rhenium, osmium, and iridium. Dalton Transactions . 2018;47(30):9934–9974. doi: 10.1039/c8dt01858h. - DOI - PubMed
    1. Savjani K. T., Gajjar A. K., Savjani J. K. Drug solubility: importance and enhancement techniques. ISRN Pharmaceutics . 2012;2012:10. doi: 10.5402/2012/195727.195727 - DOI - PMC - PubMed
    1. Giammei C., Balber T., Bencurova K., et al. Sorbitol as a polar pharmacological modifier to enhance the hydrophilicity of Tc-99m-tricarbonyl-based radiopharmaceuticals. Molecules . 2020;25 - PMC - PubMed

LinkOut - more resources